Cagrilintide research compound — long-acting amylin analog studied in satiety, food intake, and glucose pathway research.

Cagrilintide is a long-acting amylin analog research compound. Amylin is a 37-amino-acid hormone co-secreted with insulin from pancreatic beta cells, and Cagrilintide’s modified structure provides a half-life suitable for weekly research dosing.
Cagrilintide activates amylin receptors (calcitonin receptor combined with RAMP proteins). Research investigates its effects on gastric emptying, satiety signaling via area postrema, and complementary action with GLP-1 pathways.
Used in: amylin receptor research, satiety and food intake studies, GLP-1/amylin combination research (e.g., CagriSema studies), gastric motility research.
| Compound | Cagrilintide |
| Available Strengths | 5mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.